Home Gilead Sciences, Mobiquity make significant healthcare investment in London
 

Keywords :   


Gilead Sciences, Mobiquity make significant healthcare investment in London

2015-02-09 16:30:46| Biotech - Topix.net

London's status as a leading centre for the life sciences, financial and digital industries has attracted significant new investment by two leading US companies, announced today as Mayor of London Boris Johnson visited Boston as part of a trade delegation to the East Coast of the USA. Gilead Sciences, a Fortune 500 US biotechnology company, is deepening its UK presence with a new commercial HQ in the heart of London from which to grow the company's portfolio, which includes treatments for HIV/Aids, liver diseases, serious respiratory and cardiovascular diseases and cancer.

Tags: make significant london investment

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
02.07Atlantic Tropical Weather Outlook
02.07Summary for Hurricane Beryl (AT2/AL022024)
02.07Hurricane Beryl Public Advisory Number 13A
02.07Hurricane Beryl Graphics
02.07American Simmental Association announces Fall Focus 2024 in Amarillo, Texas
02.07Ribbon cutting celebrates new feedlot research, teaching, extension center
02.07Eastern North Pacific Tropical Weather Outlook
02.07The fastest data in the world
More »